Able Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Buy
313
+57
+22% +$57.8K 0.07% 105
2025
Q4
$236K Buy
+256
New +$245K 0.07% 100
2024
Q1
Sell
-129
Closed -$75.5K 360
2023
Q4
$75.5K Buy
+129
New +$75.3K 0.07% 110

Other funds holding LLY

Able Wealth Management's LLY Position: Q1 2026 in Review

Able Wealth Management increased its Eli Lilly (LLY) stake by 22% in Q1 2026, buying an estimated $57.8K and bringing the position to 313 shares worth $255K. The position accounts for 0.07% of the portfolio, ranked #105.

Able Wealth Management first reported a position in LLY in Q4 2023 and has held it in 3 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Able Wealth Management held 313 shares of Eli Lilly worth $255K as of Q1 2026.
  • Able Wealth Management bought 57 Eli Lilly shares in Q1 2026, an estimated $57.8K.
  • Eli Lilly made up 0.07% of Able Wealth Management's portfolio in Q1 2026, its #105 holding.
  • Able Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 3 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Able Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.